Navigation Links
New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
Date:4/9/2008

BOSTON, April 9, 2008 /PRNewswire/ -- New devices and research for mechanical circulatory support in pediatrics from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Circulatory Support Program will be discussed at the International Society for Heart and Lung Transplantation (ISHLT) 28th Annual Meeting and Scientific Sessions. The meeting is ongoing this week at the Boston Marriott Copley Place and Hynes Convention Center.

The use of mechanical circulatory support devices (MCSDs) is shown to decrease wait list mortality and improve efficiency of organ utilization in children. Close to 1,800 children with congenital heart defects die each year, and 25 percent of the 36,000 babies born with these malformations require invasive treatment within the first year of life. Despite rapid technologic advances that have allowed development of sophisticated MCSDs for adults, very few such options exist for infants and children in need of mechanical circulatory support.

Acknowledging this vacancy, the NHLBI Pediatric Circulatory Support Program awarded five contracts to develop a family of devices. These include:
-- An implantable mixed-flow ventricular assist device designed

specifically for patients up to two years of age

-- Another mixed-flow ventricular assist device that can be implanted

intravascularly or extravascularly depending on size

-- Compact integrated pediatric cardiopulmonary assist systems

-- Apically implanted axial-flow ventricular assist device

-- Pulsatile-flow ventricular assist device.

"The field of pediatric mechanical circulatory support received a boost from the NHLBI program even beyond the much needed support for the development of these innovative new devices. There is a real sense of momentum in this field and the NHLBI program is largely responsible for this," said Brian Duncan, M.D., Pediatric and Congenital Heart Sur
'/>"/>

SOURCE International Society for Heart and Lung Transplantation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
2. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
3. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
4. Navigenics(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. ACORNs Oncology-focused Contract Research Organization Exceeds Projections
7. Low Acid Coffee Backed By Scientific Research
8. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
9. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
11. Velos to Develop Key System Interface for Clinical Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...K,Calif.,Nov.25/PRNewswire/--PraxisElectronicMedic...ademyofFamilyPhysicians,(AAFP)FamilyPracticeManage...medicalquality,healthmaintenance,anddiseasemanagem...salsoranked#1amongdoctorsindicatingtheirEMRhadapos...alsorankednumberoneinthecountryinprovidingexcellen...
(Date:11/25/2009)...HIA,Nov.25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES...ny,sPresidentandCEO,andKeithSchneck,theCompany,sEx...the21stAnnualPiperJaffrayHealthCareConferenceat1:3... Interestedpartiesmayaccessthepresentationbyvisiti...m .Thewebcastmayalsobeaccessedat http://www.corpor...
(Date:11/25/2009)...RK,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTech...oamthatstopsseverebleeding,wonfirstprizeand$10,000...ecurityChallenge2009,companyofficialsannouncetoday...eworld,Remedium,steampitchedtheirinventionattheGSC...iness. ,, Remedium( www.remediumtechnologies.co...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Key to evolutionary fitness 3A Cut the calories 9078 1Key to evolutionary fitness 3A Cut the calories 9078 2First step to converting solar energy using artificial leaf 12859 1First step to converting solar energy using artificial leaf 12859 2Specialized California Medical Center 28Heart411 com 29 Offers Top Notch Cardiothoracic Surgery 50474 1Specialized California Medical Center 28Heart411 com 29 Offers Top Notch Cardiothoracic Surgery 50474 2
... Md., April 27 As body mass increases, so does ... according to Baltimore researchers. A new study, ...f the American Urological Association (AUA), asses...luated insurance claims of 95,962 subjects over a ...ify whether obesity is associated with a UTI diagn...
... Build on Pivotal Phase III Study for the Treatmen...., April 27 Ferring Pharmaceuticals announced tod...garelix for injection, a new injectable gonadotrop...proved by the U.S. Food and Drug Administration (F...d prostate cancer. The announcement was made at...
Other Medicine Technology:Obesity Associated With Higher Risk for Urinary Tract Infections 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 3Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 4Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 5
(Date:11/26/2009)...25 years, the number of Americans living with diab...ion in 2009 to 44.1 million in 2034. Over the same...rising from $113 billion to $336 billion, even wit...chers based at the University of Chicago report in...mber of those with diabetes covered by Medicare wi...
(Date:11/26/2009)...ger thrill when on an emotional rollercoaster, stu...y News) -- Call it the fear factor meets the jubil...ctators -- especially those who root for the winni... a closely contested match and victory was in doub..., Chew on that this Thanksgiving weekend as you,...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a...rolina, today announced the expansion of its servi...entist, Dr. Doug Macmillan. , ...ntal is pleased to announce that Dr. Doug Macmilla...mpleted an additional advanced training seminar. ...
(Date:11/25/2009)...Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopl...ropractorcanalsogivepatientsthehelptheyneed.TMJsta...jaw(mandible)contacts/connectswithyourskull(tempor...TMJdysfunctionarepainwithchewing,clickingorpopping...functionincluding:headaches,fatigue,sleepdisturban...
(Date:11/25/2009)...OandCALGARY,Nov.25/PRNewswire/-SentinelleMedicalIn...MRI)coilsandsoftwareandCalgaryScientificInc.,alead...oducedawebversionofAegis(TM)Breast4DAdvancedVisual...efirsttrulyzero-footprintWebclientbasedmedicalimag...TM)platformallowsforzero-footprintaccess-requiring...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...ns of deep concern and disappointment about report...orward without addressing several issues that are ...ies were sent today to congressional leaders by th... and medical student members of ACP. , Dr. Dale t...
... 20, 2007) A Jekyll-Hyde mechanism that both prot...be the basis for new cancer-fighting drugs. , Sci...n Lindquist have discovered that a certain transcr...s the survival of cancer cells. , According to t...
...ose research is challenging conventional thinking ...fit cardiac patients, has secured funding to furth...from the Universitys Faculty of Biological Science...For a long time the cardiovascular benefits of sta...
...he job the agency is doing , , THURSDAY, ...Americans depend on prescription medicines for hea...nt,s role in keeping those medicines safe, a new s...ged the agency,s performance as poor. , "The Ameri...
... Developments in Solid Organ Transplantation, DAL...w",is the focus of a one-day meeting scheduled for...exas. Co-sponsored by the American Society of,Tran...ents in solid organ transplantation medicine and h...
...Enables Health Care Providers to Increase ...s, SAN ANTONIO, Sept. 20 AT&T Inc. (NYSE: T ),t...folio of radio frequency,identification (RFID) tra...AT&T is the first network services company to prov...
Other Medicine News:Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 3Health News:Heat shock proteins are co-opted for cancer 2Health News:Research to shed new light on how statins benefit heart patients 2Health News:Americans Confused About FDA and Drug Safety 2Health News:Americans Confused About FDA and Drug Safety 3Health News:Americans Confused About FDA and Drug Safety 4Health News:Dallas-Area Transplant Meeting Puts Spotlight on Key Issues 2Health News:AT&T Offers 'Network Industry-First' RFID Solution for Health Care Organizations 2Health News:AT&T Offers 'Network Industry-First' RFID Solution for Health Care Organizations 3
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...roscopic condenser humidifiers (HCH) capture the p... in the inspired gas. Small and compact, they are ...groscopic benefits. Depending on the tidal volume ...ume model., ,The adult HCH is ideal for patient t...
Medicine Products: